![[höher]](/style/images/multi_up.png)
Eine Ebene höherGruppiert nach: Dokumententyp |
Veröffentlichungsdatum
Anzahl der Publikationen: 10
2022
Li, Minglun; Fan, Yourong; Trapp, Christian; Schmidt-Hegemann, Nina Sophie; Ma, Jing; Buchner, Alexander; Lu, Shun; Xu, Bin; Stief, Christian; Wang, Xuanbin; Zhou, Cheng; Belka, Claus und Rogowski, Paul
(2022):
Elective nodal radiotherapy with a gapless radiation field junction for oligorecurrent prostate cancer after previous radiotherapy.
In: Clinical and Translational Radiation Oncology, Bd. 39, 100571
Liu, Kaiqi; Guo, Yingying; Chen, Xiaojing; Duan, Jufeng; Li, Bei; Liu, Ming; Chen, Lin; Li, Minglun; Feng, Yibin; Li, Hongliang und Wang, Xuanbin
(2022):
Quality control, preparation process optimizing and anti-inflammatory effects of Premna Puberula Pamp. Pectin.
In: Heliyon, Bd. 8, Nr. 10, e11082
Wang, Dongpeng; Duan, Jufeng; Chen, Xiao-Jing; Liu, Kaiqi; Guo, Yingying; Shi, Run; Li, Sha; Liu, Ming; Zhao, Lijun; Li, Bei; Liu, Hongtao; Li, Minglun; Feng, Yibin; Li, Hongliang und Wang, Xuanbin
(2022):
Pharmacokinetic characteristics of emodin in polygoni Multiflori Radix Praeparata.
In: Journal of Ethnopharmacology, Bd. 303, 115945
Shi, Run; Wang, Xin; Wu, Yang; Xu, Bin; Zhao, Tianyu; Trapp, Christian; Wang, Xuanbin; Unger, Kristian; Zhou, Cheng; Lu, Shun; Buchner, Alexander; Schulz, Gerald Bastian; Cao, Fengjun; Belka, Claus; Su, Chuan; Li, Minglun und Shu, Yongqian
(2022):
APOBEC-mediated mutagenesis is a favorable predictor of prognosis and immunotherapy for bladder cancer patients: evidence from pan-cancer analysis and multiple databases.
In: Theranostics, Bd. 12, Nr. 9: S. 4181-4199
2021
Wang, Dongpeng; Wang, Xian-He; Yu, Xiongjie; Cao, Fengjun; Cai, Xiaojun; Chen, Ping; Li, Minglun; Feng, Yibin; Li, Hongliang und Wang, Xuanbin
(15. April 2021):
Pharmacokinetics of Anthraquinones from Medicinal Plants.
In: Frontiers in Pharmacology, Bd. 12, 638993
[PDF, 1MB]
Shi, Run; Bao, Xuanwen; Unger, Kristian; Sun, Jing; Lu, Shun; Manapov, Farkhad; Wang, Xuanbin; Belka, Claus und Li, Minglun
(2021):
Identification and validation of hypoxia-derived gene signatures to predict clinical outcomes and therapeutic responses in stage I lung adenocarcinoma patients.
In: Theranostics, Bd. 11, Nr. 10: S. 5061-5076
Sun, Jing; Shi, Run; Zhang, Xiaowen; Fang, Da; Rauch, Josefine; Lu, Shun; Wang, Xuanbin; Kasmann, Lukas; Ma, Jing; Belka, Claus; Su, Chuan und Li, Minglun
(2021):
Characterization of immune landscape in papillary thyroid cancer reveals distinct tumor immunogenicity and implications for immunotherapy.
In: Oncoimmunology, Bd. 10, Nr. 1, e1964189
2020
Shi, Run; Bao, Xuanwen; Weischenfeldt, Joachim; Schaefer, Christian; Rogowski, Paul; Schmidt-Hegemann, Nina-Sophie; Unger, Kristian; Lauber, Kirsten; Wang, Xuanbin; Buchner, Alexander; Stief, Christian; Schlomm, Thorsten; Belka, Claus und Li, Minglun
(2020):
A Novel Gene Signature-Based Model Predicts Biochemical Recurrence-Free Survival in Prostate Cancer Patients after Radical Prostatectomy.
In: Cancers, Bd. 12, Nr. 1, 1
2019
Ding, Yan; Liu, Yuechao; Li, Hongliang; Li, Yong; Li, Minglun; Liu, Ming; Wang, Xianhe; Cao, Fengjun und Wang, Xuanbin
(5. September 2019):
Chinese Medicines for Preventing and Treating Radiation-Induced Pulmonary Injury: Still a Long Way to Go.
In: Frontiers in Pharmacology, Bd. 10, 927: S. 1-10
[PDF, 2MB]
Yang, Nian; Li, Chen; Li, Hongliang; Liu, Ming; Cai, Xiaojun; Cao, Fengjun; Feng, Yibin; Li, Minglun und Wang, Xuanbin
(25. Juni 2019):
Emodin Induced SREBP1-Dependent and SREBP1-Independent Apoptosis in Hepatocellular Carcinoma Cells.
In: Frontiers in Pharmacology, Bd. 10, 709: S. 1-14
[PDF, 15MB]